Mendonca V, Pereira Sena P, Evangelista Dos Santos AC, Rodrigues Bonvicino C, Ashton-Prolla P, Epelman S et al (2022) Diverse mutational spectrum in the 13q14 chromosomal region in a Brazilian cohort of retinoblastoma. Exp Eye Res 224:109211. https://doi.org/10.1016/j.exer.2022.109211
Article CAS PubMed Google Scholar
Global Retinoblastoma Study G, Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S et al (2020) Global retinoblastoma presentation and analysis by national income level. JAMA Oncol 6:685–695. https://doi.org/10.1001/jamaoncol.2019.6716
Cruz-Galvez CC, Ordaz-Favila JC, Villar-Calvo VM, Cancino-Marentes ME, Bosch-Canto V (2022) Retinoblastoma: review and new insights. Front Oncol 12:963780. https://doi.org/10.3389/fonc.2022.963780
Article PubMed PubMed Central Google Scholar
Li N, Wang YZ, Huang DS, Zhang Y, Zhang WL, Ma JM et al (2022) Clinical analysis of 16 distant metastatic retinoblastoma cases with event-free survival. Cancer Manag Res 14:367–375. https://doi.org/10.2147/CMAR.S349035
Article PubMed PubMed Central Google Scholar
Shields CL, Fulco EM, Arias JD, Alarcon C, Pellegrini M, Rishi P et al (2013) Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond) 27:253–264. https://doi.org/10.1038/eye.2012.175
Article CAS PubMed Google Scholar
Tanveer S, Zafar F, Bibi H, Haroon H, Ahmad O, Iqbal MS et al (2024) Advancements in retinoblastoma treatment: unraveling the potential of intravitreal chemotherapy. Cureus 16:e53012. https://doi.org/10.7759/cureus.53012
Article PubMed PubMed Central Google Scholar
Utomo PT, Respatika D, Ardianto B, Rinonce HT, Heriyanto DS, Dibyasakti BA et al (2022) Lag time, high-risk histopathological features, metastasis, and survival interrelation in retinoblastoma: a perspective from lower-middle income country. Int J Ophthalmol 15:1994–2000. https://doi.org/10.18240/ijo.2022.12.15
Article PubMed PubMed Central Google Scholar
Kristensen LS, Jakobsen T, Hager H, Kjems J (2022) The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol 19:188–206. https://doi.org/10.1038/s41571-021-00585-y
Article CAS PubMed Google Scholar
Tao M, Zheng M, Xu Y, Ma S, Zhang W, Ju S (2021) CircRNAs and their regulatory roles in cancers. Mol Med 27:94. https://doi.org/10.1186/s10020-021-00359-3
Article CAS PubMed PubMed Central Google Scholar
Wu W, Zhang Y, Yang M (2024) Emerging role of circular RNAs in the pathogenesis of retinoblastoma. Ophthalmic Res 67:51–61. https://doi.org/10.1159/000535329
Article CAS PubMed Google Scholar
Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J et al (2013) Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19:141–157. https://doi.org/10.1261/rna.035667.112
Article CAS PubMed PubMed Central Google Scholar
Salzman J (2016) Circular RNA expression: its potential regulation and function. Trends Genet 32:309–316. https://doi.org/10.1016/j.tig.2016.03.002
Article CAS PubMed PubMed Central Google Scholar
Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong F et al (2018) Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer 17:79. https://doi.org/10.1186/s12943-018-0827-8
Article CAS PubMed PubMed Central Google Scholar
Khan S, Jha A, Panda AC, Dixit A (2021) Cancer-associated circRNA-miRNA-mRNA regulatory networks: a meta-analysis. Front Mol Biosci 8:671309. https://doi.org/10.3389/fmolb.2021.671309
Article CAS PubMed PubMed Central Google Scholar
Du J, Zhuo Y, Sun X, Nie M, Yang J, Luo X et al (2023) hsa_circ_0000285 sponging miR-582–3p promotes neuroblastoma progression by regulating the Wnt/beta-catenin signaling pathway. Open Med (Wars) 18:20230726. https://doi.org/10.1515/med-2023-0726
Article CAS PubMed Google Scholar
Centron-Broco A, Rossi F, Grelloni C, Garraffo R, Dattilo D, Giuliani A et al (2023) CircAFF1 is a circular RNA with a role in alveolar rhabdomyosarcoma cell migration. Biomedicines 11:1893. https://doi.org/10.3390/biomedicines11071893
Article CAS PubMed PubMed Central Google Scholar
Zhu X, Wan J, You X, Yang W, Zhao L (2023) Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225–5p/WT1 axis to regulate non-small cell lung cancer cell malignant behavior. Thorac Cancer 14:1969–1979. https://doi.org/10.1111/1759-7714.14943
Article CAS PubMed PubMed Central Google Scholar
Zhu Q, Hu Y, Jiang W, Ou ZL, Yao YB, Zai HY (2024) Circ-CCT2 Activates Wnt/beta-catenin signaling to facilitate hepatoblastoma development by stabilizing PTBP1 mRNA. Cell Mol Gastroenterol Hepatol 17:175–197. https://doi.org/10.1016/j.jcmgh.2023.10.004
Article CAS PubMed Google Scholar
Sun Z, Zhang A, Hou M, Jiang T (2020) Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361–3p. Bioengineered 11:949–957. https://doi.org/10.1080/21655979.2020.1814670
Article CAS PubMed PubMed Central Google Scholar
Fu C, Wang S, Jin L, Zhang M, Li M (2021) CircTET1 inhibits retinoblastoma progression via targeting mir-492 and miR-494–3p through Wnt/beta-catenin signaling pathway. Curr Eye Res 46:978–987. https://doi.org/10.1080/02713683.2020.1843685
Article CAS PubMed Google Scholar
Zhang H, Qiu X, Song Z, Lan L, Ren X, Ye B (2022) CircCUL2 suppresses retinoblastoma cells by regulating miR-214–5p/E2F2 Axis. Anticancer Drugs 33:e218–e227. https://doi.org/10.1097/CAD.0000000000001190
Article CAS PubMed Google Scholar
Song J, Ge Y, Dong M, Guan Q, Ju M, Song X et al (2023) Molecular interplay between EIF4 family and circular RNAs in cancer: mechanisms and therapeutics. Eur J Pharmacol 954:175867. https://doi.org/10.1016/j.ejphar.2023.175867
Article CAS PubMed Google Scholar
Chan CC, Dostie J, Diem MD, Feng W, Mann M, Rappsilber J et al (2004) eIF4A3 is a novel component of the exon junction complex. RNA 10:200–209. https://doi.org/10.1261/rna.5230104
Article CAS PubMed PubMed Central Google Scholar
Amatya N, Garg AV, Gaffen SL (2017) IL-17 signaling: the Yin and the Yang. Trends Immunol 38:310–322. https://doi.org/10.1016/j.it.2017.01.006
Article CAS PubMed PubMed Central Google Scholar
Koh CH, Kim BS, Kang CY, Chung Y, Seo H (2024) IL-17 and IL-21: their immunobiology and therapeutic potentials. Immune Netw 24:e2. https://doi.org/10.4110/in.2024.24.e2
Article PubMed PubMed Central Google Scholar
Zhang C, Hu J, Yu Y (2020) CircRNA is a rising star in researches of ocular diseases. Front Cell Dev Biol 8:850. https://doi.org/10.3389/fcell.2020.00850
Article PubMed PubMed Central Google Scholar
Lyu J, Wang Y, Zheng Q, Hua P, Zhu X, Li J et al (2019) Reduction of circular RNA expression associated with human retinoblastoma. Exp Eye Res 184:278–285. https:/
留言 (0)